Imatinib for the treatment of refractory, diffuse systemic sclerosis.
Sfikakis
P P
PP
Gorgoulis
V G
VG
Katsiari
C G
CG
Evangelou
K
K
Kostopoulos
C
C
Black
C M
CM
D000328:Adult; D001549:Benzamides; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D045743:Scleroderma, Diffuse / Q000188:drug therapy*
D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate